mRNA is a rather versatile technology and offers a number of advantages. mRNA lacks genomic integration and its use results in transient expression of the encoded protein. This favorable safety profile makes mRNA especially attractive for vaccines and gene editing. mRNA is well defined chemically which ensures reproducible manufacturing at high yield, purity and activity. Improvements of lipid nanoparticle formulations as a vehicle for in vivo systemic delivery of mRNA has greatly favored the development of in vivo transfection strategies.
This report aims to provide a comprehensive presentation of the global market for mRNA Vaccines & Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding mRNA Vaccines & Therapeutics. This report contains market size and forecasts of mRNA Vaccines & Therapeutics in global, including the following market information:
Global mRNA Vaccines & Therapeutics Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global mRNA Vaccines & Therapeutics Market Sales, 2018-2023, 2024-2029, (M Doses)
Global top five mRNA Vaccines & Therapeutics companies in 2022 (%)
The global mRNA Vaccines & Therapeutics market was valued at US$ 37740 million in 2022 and is projected to reach US$ 13790 million by 2029, at a CAGR of -13.4% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global core mRNA vaccines & therapeutics manufacturers include Moderna Therapeutics, CureVac etc. The top 3 companies hold a share about 65%. Europe is the largest market, with a share about 10%, followed by Asia Pacific and North America.
We surveyed the mRNA Vaccines & Therapeutics manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global mRNA Vaccines & Therapeutics Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (M Doses)
Global mRNA Vaccines & Therapeutics Market Segment Percentages, by Type, 2022 (%)
Infectious Disease Vaccines
Cancer Vaccines
Global mRNA Vaccines & Therapeutics Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (M Doses)
Global mRNA Vaccines & Therapeutics Market Segment Percentages, by Application, 2022 (%)
Infectious Disease
Cancer
Global mRNA Vaccines & Therapeutics Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (M Doses)
Global mRNA Vaccines & Therapeutics Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies mRNA Vaccines & Therapeutics revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies mRNA Vaccines & Therapeutics revenues share in global market, 2022 (%)
Key companies mRNA Vaccines & Therapeutics sales in global market, 2018-2023 (Estimated), (M Doses)
Key companies mRNA Vaccines & Therapeutics sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Moderna Therapeutics
CureVac
Translate Bio
BioNTech
Sangamo Therapeutics
Argos Therapeutics
In-Cell-Art
eTheRNA
Ethris
Tiba Biotechnology
Outline of Major Chapters:
Chapter 1: Introduces the definition of mRNA Vaccines & Therapeutics, market overview.
Chapter 2: Global mRNA Vaccines & Therapeutics market size in revenue and volume.
Chapter 3: Detailed analysis of mRNA Vaccines & Therapeutics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of mRNA Vaccines & Therapeutics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global mRNA Vaccines & Therapeutics capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 mRNA Vaccines & Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global mRNA Vaccines & Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global mRNA Vaccines & Therapeutics Overall Market Size
2.1 Global mRNA Vaccines & Therapeutics Market Size: 2022 VS 2029
2.2 Global mRNA Vaccines & Therapeutics Revenue, Prospects & Forecasts: 2018-2029
2.3 Global mRNA Vaccines & Therapeutics Sales: 2018-2029
3 Company Landscape
3.1 Top mRNA Vaccines & Therapeutics Players in Global Market
3.2 Top Global mRNA Vaccines & Therapeutics Companies Ranked by Revenue
3.3 Global mRNA Vaccines & Therapeutics Revenue by Companies
3.4 Global mRNA Vaccines & Therapeutics Sales by Companies
3.5 Global mRNA Vaccines & Therapeutics Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 mRNA Vaccines & Therapeutics Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers mRNA Vaccines & Therapeutics Product Type
3.8 Tier 1, Tier 2 and Tier 3 mRNA Vaccines & Therapeutics Players in Global Market
3.8.1 List of Global Tier 1 mRNA Vaccines & Therapeutics Companies
3.8.2 List of Global Tier 2 and Tier 3 mRNA Vaccines & Therapeutics Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global mRNA Vaccines & Therapeutics Market Size Markets, 2022 & 2029
4.1.2 Infectious Disease Vaccines
4.1.3 Cancer Vaccines
4.2 By Type - Global mRNA Vaccines & Therapeutics Revenue & Forecasts
4.2.1 By Type - Global mRNA Vaccines & Therapeutics Revenue, 2018-2023
4.2.2 By Type - Global mRNA Vaccines & Therapeutics Revenue, 2024-2029
4.2.3 By Type - Global mRNA Vaccines & Therapeutics Revenue Market Share, 2018-2029
4.3 By Type - Global mRNA Vaccines & Therapeutics Sales & Forecasts
4.3.1 By Type - Global mRNA Vaccines & Therapeutics Sales, 2018-2023
4.3.2 By Type - Global mRNA Vaccines & Therapeutics Sales, 2024-2029
4.3.3 By Type - Global mRNA Vaccines & Therapeutics Sales Market Share, 2018-2029
4.4 By Type - Global mRNA Vaccines & Therapeutics Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global mRNA Vaccines & Therapeutics Market Size, 2022 & 2029
5.1.2 Infectious Disease
5.1.3 Cancer
5.2 By Application - Global mRNA Vaccines & Therapeutics Revenue & Forecasts
5.2.1 By Application - Global mRNA Vaccines & Therapeutics Revenue, 2018-2023
5.2.2 By Application - Global mRNA Vaccines & Therapeutics Revenue, 2024-2029
5.2.3 By Application - Global mRNA Vaccines & Therapeutics Revenue Market Share, 2018-2029
5.3 By Application - Global mRNA Vaccines & Therapeutics Sales & Forecasts
5.3.1 By Application - Global mRNA Vaccines & Therapeutics Sales, 2018-2023
5.3.2 By Application - Global mRNA Vaccines & Therapeutics Sales, 2024-2029
5.3.3 By Application - Global mRNA Vaccines & Therapeutics Sales Market Share, 2018-2029
5.4 By Application - Global mRNA Vaccines & Therapeutics Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global mRNA Vaccines & Therapeutics Market Size, 2022 & 2029
6.2 By Region - Global mRNA Vaccines & Therapeutics Revenue & Forecasts
6.2.1 By Region - Global mRNA Vaccines & Therapeutics Revenue, 2018-2023
6.2.2 By Region - Global mRNA Vaccines & Therapeutics Revenue, 2024-2029
6.2.3 By Region - Global mRNA Vaccines & Therapeutics Revenue Market Share, 2018-2029
6.3 By Region - Global mRNA Vaccines & Therapeutics Sales & Forecasts
6.3.1 By Region - Global mRNA Vaccines & Therapeutics Sales, 2018-2023
6.3.2 By Region - Global mRNA Vaccines & Therapeutics Sales, 2024-2029
6.3.3 By Region - Global mRNA Vaccines & Therapeutics Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America mRNA Vaccines & Therapeutics Revenue, 2018-2029
6.4.2 By Country - North America mRNA Vaccines & Therapeutics Sales, 2018-2029
6.4.3 US mRNA Vaccines & Therapeutics Market Size, 2018-2029
6.4.4 Canada mRNA Vaccines & Therapeutics Market Size, 2018-2029
6.4.5 Mexico mRNA Vaccines & Therapeutics Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe mRNA Vaccines & Therapeutics Revenue, 2018-2029
6.5.2 By Country - Europe mRNA Vaccines & Therapeutics Sales, 2018-2029
6.5.3 Germany mRNA Vaccines & Therapeutics Market Size, 2018-2029
6.5.4 France mRNA Vaccines & Therapeutics Market Size, 2018-2029
6.5.5 U.K. mRNA Vaccines & Therapeutics Market Size, 2018-2029
6.5.6 Italy mRNA Vaccines & Therapeutics Market Size, 2018-2029
6.5.7 Russia mRNA Vaccines & Therapeutics Market Size, 2018-2029
6.5.8 Nordic Countries mRNA Vaccines & Therapeutics Market Size, 2018-2029
6.5.9 Benelux mRNA Vaccines & Therapeutics Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia mRNA Vaccines & Therapeutics Revenue, 2018-2029
6.6.2 By Region - Asia mRNA Vaccines & Therapeutics Sales, 2018-2029
6.6.3 China mRNA Vaccines & Therapeutics Market Size, 2018-2029
6.6.4 Japan mRNA Vaccines & Therapeutics Market Size, 2018-2029
6.6.5 South Korea mRNA Vaccines & Therapeutics Market Size, 2018-2029
6.6.6 Southeast Asia mRNA Vaccines & Therapeutics Market Size, 2018-2029
6.6.7 India mRNA Vaccines & Therapeutics Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America mRNA Vaccines & Therapeutics Revenue, 2018-2029
6.7.2 By Country - South America mRNA Vaccines & Therapeutics Sales, 2018-2029
6.7.3 Brazil mRNA Vaccines & Therapeutics Market Size, 2018-2029
6.7.4 Argentina mRNA Vaccines & Therapeutics Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa mRNA Vaccines & Therapeutics Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa mRNA Vaccines & Therapeutics Sales, 2018-2029
6.8.3 Turkey mRNA Vaccines & Therapeutics Market Size, 2018-2029
6.8.4 Israel mRNA Vaccines & Therapeutics Market Size, 2018-2029
6.8.5 Saudi Arabia mRNA Vaccines & Therapeutics Market Size, 2018-2029
6.8.6 UAE mRNA Vaccines & Therapeutics Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Moderna Therapeutics
7.1.1 Moderna Therapeutics Company Summary
7.1.2 Moderna Therapeutics Business Overview
7.1.3 Moderna Therapeutics mRNA Vaccines & Therapeutics Major Product Offerings
7.1.4 Moderna Therapeutics mRNA Vaccines & Therapeutics Sales and Revenue in Global (2018-2023)
7.1.5 Moderna Therapeutics Key News & Latest Developments
7.2 CureVac
7.2.1 CureVac Company Summary
7.2.2 CureVac Business Overview
7.2.3 CureVac mRNA Vaccines & Therapeutics Major Product Offerings
7.2.4 CureVac mRNA Vaccines & Therapeutics Sales and Revenue in Global (2018-2023)
7.2.5 CureVac Key News & Latest Developments
7.3 Translate Bio
7.3.1 Translate Bio Company Summary
7.3.2 Translate Bio Business Overview
7.3.3 Translate Bio mRNA Vaccines & Therapeutics Major Product Offerings
7.3.4 Translate Bio mRNA Vaccines & Therapeutics Sales and Revenue in Global (2018-2023)
7.3.5 Translate Bio Key News & Latest Developments
7.4 BioNTech
7.4.1 BioNTech Company Summary
7.4.2 BioNTech Business Overview
7.4.3 BioNTech mRNA Vaccines & Therapeutics Major Product Offerings
7.4.4 BioNTech mRNA Vaccines & Therapeutics Sales and Revenue in Global (2018-2023)
7.4.5 BioNTech Key News & Latest Developments
7.5 Sangamo Therapeutics
7.5.1 Sangamo Therapeutics Company Summary
7.5.2 Sangamo Therapeutics Business Overview
7.5.3 Sangamo Therapeutics mRNA Vaccines & Therapeutics Major Product Offerings
7.5.4 Sangamo Therapeutics mRNA Vaccines & Therapeutics Sales and Revenue in Global (2018-2023)
7.5.5 Sangamo Therapeutics Key News & Latest Developments
7.6 Argos Therapeutics
7.6.1 Argos Therapeutics Company Summary
7.6.2 Argos Therapeutics Business Overview
7.6.3 Argos Therapeutics mRNA Vaccines & Therapeutics Major Product Offerings
7.6.4 Argos Therapeutics mRNA Vaccines & Therapeutics Sales and Revenue in Global (2018-2023)
7.6.5 Argos Therapeutics Key News & Latest Developments
7.7 In-Cell-Art
7.7.1 In-Cell-Art Company Summary
7.7.2 In-Cell-Art Business Overview
7.7.3 In-Cell-Art mRNA Vaccines & Therapeutics Major Product Offerings
7.7.4 In-Cell-Art mRNA Vaccines & Therapeutics Sales and Revenue in Global (2018-2023)
7.7.5 In-Cell-Art Key News & Latest Developments
7.8 eTheRNA
7.8.1 eTheRNA Company Summary
7.8.2 eTheRNA Business Overview
7.8.3 eTheRNA mRNA Vaccines & Therapeutics Major Product Offerings
7.8.4 eTheRNA mRNA Vaccines & Therapeutics Sales and Revenue in Global (2018-2023)
7.8.5 eTheRNA Key News & Latest Developments
7.9 Ethris
7.9.1 Ethris Company Summary
7.9.2 Ethris Business Overview
7.9.3 Ethris mRNA Vaccines & Therapeutics Major Product Offerings
7.9.4 Ethris mRNA Vaccines & Therapeutics Sales and Revenue in Global (2018-2023)
7.9.5 Ethris Key News & Latest Developments
7.10 Tiba Biotechnology
7.10.1 Tiba Biotechnology Company Summary
7.10.2 Tiba Biotechnology Business Overview
7.10.3 Tiba Biotechnology mRNA Vaccines & Therapeutics Major Product Offerings
7.10.4 Tiba Biotechnology mRNA Vaccines & Therapeutics Sales and Revenue in Global (2018-2023)
7.10.5 Tiba Biotechnology Key News & Latest Developments
8 Global mRNA Vaccines & Therapeutics Production Capacity, Analysis
8.1 Global mRNA Vaccines & Therapeutics Production Capacity, 2018-2029
8.2 mRNA Vaccines & Therapeutics Production Capacity of Key Manufacturers in Global Market
8.3 Global mRNA Vaccines & Therapeutics Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 mRNA Vaccines & Therapeutics Supply Chain Analysis
10.1 mRNA Vaccines & Therapeutics Industry Value Chain
10.2 mRNA Vaccines & Therapeutics Upstream Market
10.3 mRNA Vaccines & Therapeutics Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 mRNA Vaccines & Therapeutics Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of mRNA Vaccines & Therapeutics in Global Market
Table 2. Top mRNA Vaccines & Therapeutics Players in Global Market, Ranking by Revenue (2022)
Table 3. Global mRNA Vaccines & Therapeutics Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global mRNA Vaccines & Therapeutics Revenue Share by Companies, 2018-2023
Table 5. Global mRNA Vaccines & Therapeutics Sales by Companies, (M Doses), 2018-2023
Table 6. Global mRNA Vaccines & Therapeutics Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers mRNA Vaccines & Therapeutics Price (2018-2023) & (USD/Doses)
Table 8. Global Manufacturers mRNA Vaccines & Therapeutics Product Type
Table 9. List of Global Tier 1 mRNA Vaccines & Therapeutics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 mRNA Vaccines & Therapeutics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global mRNA Vaccines & Therapeutics Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global mRNA Vaccines & Therapeutics Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global mRNA Vaccines & Therapeutics Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global mRNA Vaccines & Therapeutics Sales (M Doses), 2018-2023
Table 15. By Type - Global mRNA Vaccines & Therapeutics Sales (M Doses), 2024-2029
Table 16. By Application ? Global mRNA Vaccines & Therapeutics Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global mRNA Vaccines & Therapeutics Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global mRNA Vaccines & Therapeutics Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global mRNA Vaccines & Therapeutics Sales (M Doses), 2018-2023
Table 20. By Application - Global mRNA Vaccines & Therapeutics Sales (M Doses), 2024-2029
Table 21. By Region ? Global mRNA Vaccines & Therapeutics Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global mRNA Vaccines & Therapeutics Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global mRNA Vaccines & Therapeutics Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global mRNA Vaccines & Therapeutics Sales (M Doses), 2018-2023
Table 25. By Region - Global mRNA Vaccines & Therapeutics Sales (M Doses), 2024-2029
Table 26. By Country - North America mRNA Vaccines & Therapeutics Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America mRNA Vaccines & Therapeutics Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America mRNA Vaccines & Therapeutics Sales, (M Doses), 2018-2023
Table 29. By Country - North America mRNA Vaccines & Therapeutics Sales, (M Doses), 2024-2029
Table 30. By Country - Europe mRNA Vaccines & Therapeutics Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe mRNA Vaccines & Therapeutics Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe mRNA Vaccines & Therapeutics Sales, (M Doses), 2018-2023
Table 33. By Country - Europe mRNA Vaccines & Therapeutics Sales, (M Doses), 2024-2029
Table 34. By Region - Asia mRNA Vaccines & Therapeutics Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia mRNA Vaccines & Therapeutics Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia mRNA Vaccines & Therapeutics Sales, (M Doses), 2018-2023
Table 37. By Region - Asia mRNA Vaccines & Therapeutics Sales, (M Doses), 2024-2029
Table 38. By Country - South America mRNA Vaccines & Therapeutics Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America mRNA Vaccines & Therapeutics Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America mRNA Vaccines & Therapeutics Sales, (M Doses), 2018-2023
Table 41. By Country - South America mRNA Vaccines & Therapeutics Sales, (M Doses), 2024-2029
Table 42. By Country - Middle East & Africa mRNA Vaccines & Therapeutics Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa mRNA Vaccines & Therapeutics Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa mRNA Vaccines & Therapeutics Sales, (M Doses), 2018-2023
Table 45. By Country - Middle East & Africa mRNA Vaccines & Therapeutics Sales, (M Doses), 2024-2029
Table 46. Moderna Therapeutics Company Summary
Table 47. Moderna Therapeutics mRNA Vaccines & Therapeutics Product Offerings
Table 48. Moderna Therapeutics mRNA Vaccines & Therapeutics Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2018-2023)
Table 49. Moderna Therapeutics Key News & Latest Developments
Table 50. CureVac Company Summary
Table 51. CureVac mRNA Vaccines & Therapeutics Product Offerings
Table 52. CureVac mRNA Vaccines & Therapeutics Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2018-2023)
Table 53. CureVac Key News & Latest Developments
Table 54. Translate Bio Company Summary
Table 55. Translate Bio mRNA Vaccines & Therapeutics Product Offerings
Table 56. Translate Bio mRNA Vaccines & Therapeutics Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2018-2023)
Table 57. Translate Bio Key News & Latest Developments
Table 58. BioNTech Company Summary
Table 59. BioNTech mRNA Vaccines & Therapeutics Product Offerings
Table 60. BioNTech mRNA Vaccines & Therapeutics Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2018-2023)
Table 61. BioNTech Key News & Latest Developments
Table 62. Sangamo Therapeutics Company Summary
Table 63. Sangamo Therapeutics mRNA Vaccines & Therapeutics Product Offerings
Table 64. Sangamo Therapeutics mRNA Vaccines & Therapeutics Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2018-2023)
Table 65. Sangamo Therapeutics Key News & Latest Developments
Table 66. Argos Therapeutics Company Summary
Table 67. Argos Therapeutics mRNA Vaccines & Therapeutics Product Offerings
Table 68. Argos Therapeutics mRNA Vaccines & Therapeutics Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2018-2023)
Table 69. Argos Therapeutics Key News & Latest Developments
Table 70. In-Cell-Art Company Summary
Table 71. In-Cell-Art mRNA Vaccines & Therapeutics Product Offerings
Table 72. In-Cell-Art mRNA Vaccines & Therapeutics Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2018-2023)
Table 73. In-Cell-Art Key News & Latest Developments
Table 74. eTheRNA Company Summary
Table 75. eTheRNA mRNA Vaccines & Therapeutics Product Offerings
Table 76. eTheRNA mRNA Vaccines & Therapeutics Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2018-2023)
Table 77. eTheRNA Key News & Latest Developments
Table 78. Ethris Company Summary
Table 79. Ethris mRNA Vaccines & Therapeutics Product Offerings
Table 80. Ethris mRNA Vaccines & Therapeutics Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2018-2023)
Table 81. Ethris Key News & Latest Developments
Table 82. Tiba Biotechnology Company Summary
Table 83. Tiba Biotechnology mRNA Vaccines & Therapeutics Product Offerings
Table 84. Tiba Biotechnology mRNA Vaccines & Therapeutics Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2018-2023)
Table 85. Tiba Biotechnology Key News & Latest Developments
Table 86. mRNA Vaccines & Therapeutics Production Capacity (M Doses) of Key Manufacturers in Global Market, 2021-2023 (M Doses)
Table 87. Global mRNA Vaccines & Therapeutics Capacity Market Share of Key Manufacturers, 2021-2023
Table 88. Global mRNA Vaccines & Therapeutics Production by Region, 2018-2023 (M Doses)
Table 89. Global mRNA Vaccines & Therapeutics Production by Region, 2024-2029 (M Doses)
Table 90. mRNA Vaccines & Therapeutics Market Opportunities & Trends in Global Market
Table 91. mRNA Vaccines & Therapeutics Market Drivers in Global Market
Table 92. mRNA Vaccines & Therapeutics Market Restraints in Global Market
Table 93. mRNA Vaccines & Therapeutics Raw Materials
Table 94. mRNA Vaccines & Therapeutics Raw Materials Suppliers in Global Market
Table 95. Typical mRNA Vaccines & Therapeutics Downstream
Table 96. mRNA Vaccines & Therapeutics Downstream Clients in Global Market
Table 97. mRNA Vaccines & Therapeutics Distributors and Sales Agents in Global Market
List of Figures
Figure 1. mRNA Vaccines & Therapeutics Segment by Type in 2022
Figure 2. mRNA Vaccines & Therapeutics Segment by Application in 2022
Figure 3. Global mRNA Vaccines & Therapeutics Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global mRNA Vaccines & Therapeutics Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global mRNA Vaccines & Therapeutics Revenue, 2018-2029 (US$, Mn)
Figure 7. mRNA Vaccines & Therapeutics Sales in Global Market: 2018-2029 (M Doses)
Figure 8. The Top 3 and 5 Players Market Share by mRNA Vaccines & Therapeutics Revenue in 2022
Figure 9. By Type - Global mRNA Vaccines & Therapeutics Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global mRNA Vaccines & Therapeutics Revenue Market Share, 2018-2029
Figure 11. By Type - Global mRNA Vaccines & Therapeutics Sales Market Share, 2018-2029
Figure 12. By Type - Global mRNA Vaccines & Therapeutics Price (USD/Doses), 2018-2029
Figure 13. By Application - Global mRNA Vaccines & Therapeutics Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global mRNA Vaccines & Therapeutics Revenue Market Share, 2018-2029
Figure 15. By Application - Global mRNA Vaccines & Therapeutics Sales Market Share, 2018-2029
Figure 16. By Application - Global mRNA Vaccines & Therapeutics Price (USD/Doses), 2018-2029
Figure 17. By Region - Global mRNA Vaccines & Therapeutics Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global mRNA Vaccines & Therapeutics Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global mRNA Vaccines & Therapeutics Revenue Market Share, 2018-2029
Figure 20. By Region - Global mRNA Vaccines & Therapeutics Sales Market Share, 2018-2029
Figure 21. By Country - North America mRNA Vaccines & Therapeutics Revenue Market Share, 2018-2029
Figure 22. By Country - North America mRNA Vaccines & Therapeutics Sales Market Share, 2018-2029
Figure 23. US mRNA Vaccines & Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 24. Canada mRNA Vaccines & Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico mRNA Vaccines & Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe mRNA Vaccines & Therapeutics Revenue Market Share, 2018-2029
Figure 27. By Country - Europe mRNA Vaccines & Therapeutics Sales Market Share, 2018-2029
Figure 28. Germany mRNA Vaccines & Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 29. France mRNA Vaccines & Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. mRNA Vaccines & Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 31. Italy mRNA Vaccines & Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 32. Russia mRNA Vaccines & Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries mRNA Vaccines & Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux mRNA Vaccines & Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia mRNA Vaccines & Therapeutics Revenue Market Share, 2018-2029
Figure 36. By Region - Asia mRNA Vaccines & Therapeutics Sales Market Share, 2018-2029
Figure 37. China mRNA Vaccines & Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 38. Japan mRNA Vaccines & Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea mRNA Vaccines & Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia mRNA Vaccines & Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 41. India mRNA Vaccines & Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America mRNA Vaccines & Therapeutics Revenue Market Share, 2018-2029
Figure 43. By Country - South America mRNA Vaccines & Therapeutics Sales Market Share, 2018-2029
Figure 44. Brazil mRNA Vaccines & Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina mRNA Vaccines & Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa mRNA Vaccines & Therapeutics Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa mRNA Vaccines & Therapeutics Sales Market Share, 2018-2029
Figure 48. Turkey mRNA Vaccines & Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 49. Israel mRNA Vaccines & Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia mRNA Vaccines & Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 51. UAE mRNA Vaccines & Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 52. Global mRNA Vaccines & Therapeutics Production Capacity (M Doses), 2018-2029
Figure 53. The Percentage of Production mRNA Vaccines & Therapeutics by Region, 2022 VS 2029
Figure 54. mRNA Vaccines & Therapeutics Industry Value Chain
Figure 55. Marketing Channels
